1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Science of Science, Research Analytics & Biomedical AI SBIR Funding Opportunity (R43/R44) is sponsored by National Institutes of Health (NIH). This NIH SBIR funding opportunity supports innovative research proposals focused on advancing the “science of science” within the biomedical research ecosystem, including research analytics platforms, AI-enabled scientific evaluation tools, workforce development technologies, co…
Get alerted about grants like this
Get emailed when new opportunities from “National Institutes of Health (NIH)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
NIH Highlighted Topic: Science of Science, Research Analytics & Biomedical AI SBIR Funding Opportunity — BW&CO NIH Highlighted Topic: Advancing “Science of Science” Research to Understand and Strengthen the Biomedical Research Ecosystem Below is a brief summary. Please check the full solicitation before applying (link in resources section).
The National Institutes of Health (NIH) is encouraging innovative research proposals focused on advancing the “science of science” — a growing field dedicated to understanding and strengthening the biomedical research ecosystem.
This highlighted topic supports multidisciplinary projects that analyze how scientific discoveries are generated, translated, funded, disseminated, reproduced, commercialized, and sustained across biomedical research systems and institutions. NIH is particularly interested in projects that improve the efficiency, rigor, reproducibility, collaboration, workforce development, and commercialization outcomes of biomedical research.
Companies developing research analytics platforms, AI-enabled scientific evaluation tools, workforce development technologies, collaboration software, data-sharing infrastructure, innovation measurement systems, or translational research optimization platforms may be strong candidates for funding.
Areas of interest include biomedical workforce development, team science, research reproducibility, data standardization, innovation analytics, translational bottleneck analysis, commercialization outcomes, research capacity building, AI and data science adoption, biomedical informatics, scientific collaboration networks, and economic impact assessment of research investments.
NIH is also encouraging projects that strengthen underfunded research institutions, expand participation in biomedical research, and improve translational pathways from discovery to patient impact.
Funding is available through the NIH SBIR/STTR Program, which currently provides up to approximately $323,090 for Phase I projects and up to $2,153,927 for Phase II projects, with opportunities for additional commercialization and follow-on funding depending on project scope and implementation impact.
This highlighted topic is supported by multiple NIH Institutes and Offices including NIGMS, NLM, NIA, NIAID, NIBIB, NIDCR, NIMHD, NEI, ODSS, ORWH, and OBSSR, all of which are seeking scalable innovations that improve the effectiveness, sustainability, rigor, and impact of the biomedical research enterprise. How much funding would I receive?
Awards provide up to $323,090 for Phase I projects (up to 2 years) and $2,153,927 for Phase II projects (up to 3 years). Some topics approved by NIH may exceed these limits. Fast-Track and Phase IIB (follow-on) options allow continuous or extended funding beyond Phase II.
What could I use the funding for? Funding may support the research, development, validation, and commercialization of scientific analytics platforms, biomedical workforce technologies, research infrastructure systems, collaboration tools, and translational research optimization solutions.
Eligible activities may include: AI and machine learning platforms for research analytics and scientific evaluation Research reproducibility and scientific integrity monitoring systems Biomedical workforce development and training technologies Team science and interdisciplinary collaboration platforms Translational research optimization and commercialization analytics Data standardization, interoperability, and sharing infrastructure Research productivity and innovation measurement tools Scientific collaboration network analysis platforms Biomedical informatics and research data science technologies Economic impact and return-on-investment analysis systems for research funding Predictive analytics for scientific innovation and translational success Research capacity building technologies for underfunded institutions Health disparities and inclusive workforce development solutions Scientific publishing, peer review, and research dissemination tools AI-enabled tools supporting biomedical informatics and health AI adoption Workforce recruitment, retention, and career progression analytics Prototype development, translational studies, and implementation research Commercialization planning, regulatory preparation, and scale-up activities Funding may also support personnel, software engineering, cloud computing infrastructure, AI model development, data analytics, implementation research, collaboration systems development, workforce training programs, intellectual property protection, regulatory strategy, and commercialization activities necessary to advance a scalable and commercially viable research technology or analytics solution aligned with NIH priorities.
Are there any additional benefits I would receive? Beyond the formal funding award, awardees gain several strategic advantages: Government Validation and Credibility: Being selected for an NIH-backed SBIR grant signals technical excellence and alignment with national health and biomedical priorities. This validation builds investor and partner confidence.
Enhanced Visibility and Market Recognition: Awardees are featured in NIH and HHS announcements, helping attract partnerships, media attention, and future contracting opportunities. Access to the Federal Innovation Ecosystem: Recipients join a national network of researchers and agencies advancing life science innovation, often opening doors to collaborations with NIH laboratories and federal health programs.
Stronger Commercial and Exit Potential: By maturing technology through nondilutive funding, companies strengthen valuation, de-risk commercialization, and increase attractiveness for acquisition or follow-on private investment. What is the timeline to apply and when would I receive funding? Applications are accepted each year on January 5th, April 5th, and September 5th.
Funding is received approximately 9 months after submission. Where does this funding come from? Funding comes from the U.S. Department of Health and Human Services , with statutory set-asides requiring NIH, CDC, and FDA to devote portions of their extramural R&D budgets (3.
2% for SBIR, 0. 45% for STTR) to support small business innovation. Who is eligible to apply?
Applicants must be U.S. small business concerns (SBCs) that: Are organized for profit with a U.S. place of business. Have ≤ 500 employees including affiliates. Are > 50% owned by U.S. citizens or permanent residents, qualifying U.S. entities, or combinations thereof.
What companies and projects are likely to win? Projects that demonstrate: A clear unmet medical or public-health need , Strong scientific rationale and feasibility , High commercialization potential , supported by a realistic market and regulatory strategy, and Alignment with an NIH Institute’s or CDC/FDA Center’s specific research mission (e.g., infectious disease, digital health, diagnostics, therapeutics, or data analytics).
Competitive applicants often have an early prototype, preliminary data, and a defined path to market adoption. Are there any restrictions I should know about? Companies must complete multiple federal registrations ( SAM.
gov , Grants. gov , eRA Commons, SBA Company Registry) before applying. Foreign entities are not eligible .
Disclosure of foreign affiliations and compliance with national security screening are mandatory. Currently we do not recommend any sort of foreign affiliation. How long will it take me to prepare an application?
For a first-time applicant , preparing a competitive submission will likely take 120–200 hours in total.
Our team specializes in complex federal R&D proposals and can: Triple your likelihood of success through proven strategy and insider-aligned proposal development Reduce your time spent on the proposal by 50–80% , letting your team focus on technology and operations Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth. Review solicitation here.
Biotech Medtech Healthtech NIH Highlighted Topic: Advancing Research into the Cause and Treatment of Rare Skin Diseases NIH Highlighted Topic: Implementation Science to Optimize HIV Prevention and Treatment
According to the current listing, eligibility includes: U. S. small business concerns (SBCs) that are organized for profit with a U. S. place of business, have ≤ 500 employees including affiliates, and are > 50% owned by U. Confirm the full requirements in the official notice before applying.
The current listing shows up to $323,090 for Phase I projects; Up to $2,153,927 for Phase II projects. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Science of Science, Research Analytics & Biomedical AI SBIR Funding Opportunity (R43/R44) is funded by National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.
OMB's proposed rewrite of 2 CFR Part 200 would bar political appointees from deferring to peer reviewers and require senior-appointee sign-off on every discretionary grant. NIH new awards are already down about 34% in 2026. Here is what the merit-review changes actually say, how 'Gold Standard Science' becomes a scoring lever, why R1 universities are being written out of some solicitations, and what principal investigators and research offices should do before October 1.
Read articleNIH's June 1 omnibus reset added Direct-to-Phase II to the STTR program for the first time. The change compresses university spinouts' funding timeline from three years to fifteen months, but the 30% research-institution subaward, feasibility-evidence rules, and IP licensing mechanics are not yet sorted at most universities.
Read articleNIH committed $402 million across 601 multiyear-funded grants in the first eight months of FY 2026 — more than four times the pace of two years ago. The mechanism front-loads obligations into a single fiscal year, leaving less budget for new project starts and squeezing FY 2026 success rates. What researchers and institutions should be doing now.
Read article